Barron Amen
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Barron Amen
Barron Amen is recorded as Analyst at Piper Sandler. Barron Amen has spoken on 1 earnings call across 1 company, most recently for Sarepta Therapeutics, Inc. on November 3, 2025. The companies whose calls Barron Amen spoke on are classified in the Healthcare sector.
Barron Amen on recent calls
“If patients missed doses due to COVID, then you should expect dystrophin production on Western blot and percentage of dystrophin-positive fibers to also be impacted between COVID and non-COVID patients.”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current